Lamotrigine, serum

Lamotrigine (Lamictal) is approved for therapy of bipolar I disorder and a wide variety of seizure disorders including Lennox-Gastaut syndrome, primary generalized tonic-clonic seizures, and partial seizures. Its many off-label uses include treatment of migraine, trigeminal neuralgia, and treatment-refractory depression. Lamotrigine inhibits glutamate release (an excitatory amino acid) and voltage-sensitive sodium channels to stabilize neuronal membranes; it also weakly inhibits the 5-HT3 (serotonin) receptor.

The serum concentration should be interpreted in the context of the patient’s clinical response and may provide useful information in patients showing poor response (noncompliance?) or adverse effects, particularly when lamotrigine is co-administered with other anticonvulsant drugs.

While most patients show response to the drug when the trough concentration is in the range of 2.5 to 15.0 mcg/mL, and show signs of toxicity when the peak serum concentration is >20 mcg/mL, some patients can tolerate peak concentrations as high as 70 mcg/mL.

  • Sample of blood serum
  • We perform the test upon request